Document is current
Any future updates will be listed below
-
Authors
Ji, Niannian
Mukherjee, Neelam
Reyes, Ryan M https://orcid.org/0000-0002-9562-5809
Gelfond, Jonathan
Javors, Martin
Meeks, Joshua J.
McConkey, David J
Shu, Zhen-Ju
Ramamurthy, Chethan
Dennett, Ryan
Curiel, Tyler J https://orcid.org/0000-0001-6962-9411
Svatek, Robert S https://orcid.org/0000-0002-0239-1338
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02753309 at ClinicalTrials.govnct02753309 at ClinicalTrials.govDocuments that mention this clinical trial
Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study
https://doi.org/10.1136/jitc-2020-001941
nct04375813 at ClinicalTrials.govDocuments that mention this clinical trial
Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study
https://doi.org/10.1136/jitc-2020-001941
Documents that mention this clinical trial
Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study
https://doi.org/10.1136/jitc-2020-001941
- License Information
